Pharma Still Reeling As House Passes Trade Deal Without Market Exclusivity Provision

The North American trade pact is moving swiftly through Congress. The legislation is noticeably missing a provision that would have granted market exclusivity for biologics for 10 years. The removal of the protection was a big win for Democrats and a huge loss for the pharmaceutical industry. In other news: an Ebola vaccine, nerve drugs, biotech stocks, a subscription model for medication, and more.

from Kaiser Health News https://ift.tt/35GH9k5